EP3478248A1 - Composition moussante concentree rheo-fluidifiante et ses utilisations, notamment pour l'hygiene corporelle - Google Patents
Composition moussante concentree rheo-fluidifiante et ses utilisations, notamment pour l'hygiene corporelleInfo
- Publication number
- EP3478248A1 EP3478248A1 EP17745414.7A EP17745414A EP3478248A1 EP 3478248 A1 EP3478248 A1 EP 3478248A1 EP 17745414 A EP17745414 A EP 17745414A EP 3478248 A1 EP3478248 A1 EP 3478248A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- composition
- sodium
- mixtures
- surfactant
- chosen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 220
- 238000005187 foaming Methods 0.000 title description 6
- 239000004094 surface-active agent Substances 0.000 claims abstract description 87
- 239000002537 cosmetic Substances 0.000 claims abstract description 60
- -1 alkyl ether sulfates Chemical class 0.000 claims abstract description 41
- 239000002280 amphoteric surfactant Substances 0.000 claims abstract description 22
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 22
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 21
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 18
- 239000000194 fatty acid Substances 0.000 claims abstract description 18
- 229930195729 fatty acid Natural products 0.000 claims abstract description 18
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 16
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 14
- 235000021317 phosphate Nutrition 0.000 claims abstract description 14
- 239000007921 spray Substances 0.000 claims abstract description 12
- 150000001413 amino acids Chemical class 0.000 claims abstract description 10
- 150000003839 salts Chemical class 0.000 claims abstract description 9
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 8
- 239000011780 sodium chloride Substances 0.000 claims abstract description 8
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims abstract description 7
- 125000000129 anionic group Chemical group 0.000 claims abstract description 6
- 150000001875 compounds Chemical class 0.000 claims abstract description 6
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 5
- 150000003862 amino acid derivatives Chemical class 0.000 claims abstract description 5
- 150000001735 carboxylic acids Chemical class 0.000 claims abstract description 5
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical class OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 claims abstract description 5
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000007127 saponification reaction Methods 0.000 claims abstract description 5
- 150000008051 alkyl sulfates Chemical class 0.000 claims abstract description 3
- 229920001184 polypeptide Polymers 0.000 claims abstract description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 3
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 3
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 3
- 239000002304 perfume Substances 0.000 claims description 29
- 239000011734 sodium Substances 0.000 claims description 28
- 229910052708 sodium Inorganic materials 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 16
- 239000004480 active ingredient Substances 0.000 claims description 15
- 229940083542 sodium Drugs 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 13
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 10
- 238000004140 cleaning Methods 0.000 claims description 10
- 239000003755 preservative agent Substances 0.000 claims description 10
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 claims description 8
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 claims description 8
- 229940073499 decyl glucoside Drugs 0.000 claims description 8
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 claims description 7
- 229940073507 cocamidopropyl betaine Drugs 0.000 claims description 7
- 229940063953 ammonium lauryl sulfate Drugs 0.000 claims description 5
- 229920001223 polyethylene glycol Polymers 0.000 claims description 5
- 230000002335 preservative effect Effects 0.000 claims description 5
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 4
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 claims description 4
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 claims description 4
- 229940080421 coco glucoside Drugs 0.000 claims description 4
- 229940096362 cocoamphoacetate Drugs 0.000 claims description 4
- GLSRFBDXBWZNLH-UHFFFAOYSA-L disodium;2-chloroacetate;2-(4,5-dihydroimidazol-1-yl)ethanol;hydroxide Chemical compound [OH-].[Na+].[Na+].[O-]C(=O)CCl.OCCN1CCN=C1 GLSRFBDXBWZNLH-UHFFFAOYSA-L 0.000 claims description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical class CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 4
- 230000007613 environmental effect Effects 0.000 claims description 4
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 claims description 4
- 150000002314 glycerols Chemical class 0.000 claims description 4
- 229940074047 glyceryl cocoate Drugs 0.000 claims description 4
- 150000002332 glycine derivatives Chemical class 0.000 claims description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 4
- OGUKJRCPWCNIQL-QFHJOOASSA-N n-methyl-n-[(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl]dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO OGUKJRCPWCNIQL-QFHJOOASSA-N 0.000 claims description 4
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims description 4
- 239000010452 phosphate Substances 0.000 claims description 4
- 239000002453 shampoo Substances 0.000 claims description 4
- 229940096501 sodium cocoamphoacetate Drugs 0.000 claims description 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 4
- 150000003445 sucroses Chemical class 0.000 claims description 4
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 claims description 4
- 235000013311 vegetables Nutrition 0.000 claims description 4
- 229940084883 wheat amino acids Drugs 0.000 claims description 4
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 claims description 3
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 claims description 3
- 238000004851 dishwashing Methods 0.000 claims description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims description 3
- 150000002334 glycols Chemical class 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000001959 sucrose esters of fatty acids Substances 0.000 claims description 3
- 235000010965 sucrose esters of fatty acids Nutrition 0.000 claims description 3
- 229940104261 taurate Drugs 0.000 claims description 3
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 2
- XYTHHAXRVHHXKO-JIUYZRCGSA-N 18-[(2r,3s,4r,5r)-4,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl]oxyoctadecanoic acid;ethanol Chemical compound CCO.COC1O[C@H](CO)[C@@H](OCCCCCCCCCCCCCCCCCC(O)=O)[C@H](O)[C@H]1O XYTHHAXRVHHXKO-JIUYZRCGSA-N 0.000 claims description 2
- OUNZARDETXBPIX-UHFFFAOYSA-N 2-(2-dodecoxyethoxy)acetic acid Chemical compound CCCCCCCCCCCCOCCOCC(O)=O OUNZARDETXBPIX-UHFFFAOYSA-N 0.000 claims description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 2
- CYPKANIKIWLVMF-UHFFFAOYSA-N 2-[(2-oxo-3,4-dihydro-1h-quinolin-5-yl)oxy]acetic acid Chemical compound N1C(=O)CCC2=C1C=CC=C2OCC(=O)O CYPKANIKIWLVMF-UHFFFAOYSA-N 0.000 claims description 2
- OIALAIQRYISUEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]e Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO OIALAIQRYISUEV-UHFFFAOYSA-N 0.000 claims description 2
- MCNJOIMMYWLFBA-UHFFFAOYSA-N 2-dodecoxy-2-oxoethanesulfonic acid;sodium Chemical compound [Na].CCCCCCCCCCCCOC(=O)CS(O)(=O)=O MCNJOIMMYWLFBA-UHFFFAOYSA-N 0.000 claims description 2
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 claims description 2
- IXOCGRPBILEGOX-UHFFFAOYSA-N 3-[3-(dodecanoylamino)propyl-dimethylazaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O IXOCGRPBILEGOX-UHFFFAOYSA-N 0.000 claims description 2
- ONAIRGOTKJCYEY-XXDXYRHBSA-N CCCCCCCCCCCCCCCCCC(O)=O.O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ONAIRGOTKJCYEY-XXDXYRHBSA-N 0.000 claims description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- HDIFHQMREAYYJW-XGXNLDPDSA-N Glyceryl Ricinoleate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC(=O)OCC(O)CO HDIFHQMREAYYJW-XGXNLDPDSA-N 0.000 claims description 2
- 239000005639 Lauric acid Substances 0.000 claims description 2
- 235000021314 Palmitic acid Nutrition 0.000 claims description 2
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 claims description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 2
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 2
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 claims description 2
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 claims description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims description 2
- 239000004147 Sorbitan trioleate Substances 0.000 claims description 2
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 claims description 2
- 235000021355 Stearic acid Nutrition 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 2
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 claims description 2
- FOLJTMYCYXSPFQ-CJKAUBRRSA-N [(2r,3s,4s,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-(octadecanoyloxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl octadecanoate Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)O[C@@H]1O[C@@]1(COC(=O)CCCCCCCCCCCCCCCCC)[C@@H](O)[C@H](O)[C@@H](CO)O1 FOLJTMYCYXSPFQ-CJKAUBRRSA-N 0.000 claims description 2
- GCSPRLPXTPMSTL-IBDNADADSA-N [(2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GCSPRLPXTPMSTL-IBDNADADSA-N 0.000 claims description 2
- ZPVGIKNDGJGLCO-VGAMQAOUSA-N [(2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZPVGIKNDGJGLCO-VGAMQAOUSA-N 0.000 claims description 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-M alaninate Chemical compound CC(N)C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-M 0.000 claims description 2
- 150000001336 alkenes Chemical class 0.000 claims description 2
- MKHVZQXYWACUQC-UHFFFAOYSA-N bis(2-hydroxyethyl)azanium;dodecyl sulfate Chemical compound OCCNCCO.CCCCCCCCCCCCOS(O)(=O)=O MKHVZQXYWACUQC-UHFFFAOYSA-N 0.000 claims description 2
- MRUAUOIMASANKQ-UHFFFAOYSA-O carboxymethyl-[3-(dodecanoylamino)propyl]-dimethylazanium Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)=O MRUAUOIMASANKQ-UHFFFAOYSA-O 0.000 claims description 2
- JDRSMPFHFNXQRB-IBEHDNSVSA-N decyl glucoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JDRSMPFHFNXQRB-IBEHDNSVSA-N 0.000 claims description 2
- RNPXCFINMKSQPQ-UHFFFAOYSA-N dicetyl hydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(=O)OCCCCCCCCCCCCCCCC RNPXCFINMKSQPQ-UHFFFAOYSA-N 0.000 claims description 2
- 229940093541 dicetylphosphate Drugs 0.000 claims description 2
- KHIQYZGEUSTKSB-UHFFFAOYSA-L disodium;4-dodecoxy-4-oxo-3-sulfobutanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O.CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O KHIQYZGEUSTKSB-UHFFFAOYSA-L 0.000 claims description 2
- QVBODZPPYSSMEL-UHFFFAOYSA-N dodecyl sulfate;2-hydroxyethylazanium Chemical compound NCCO.CCCCCCCCCCCCOS(O)(=O)=O QVBODZPPYSSMEL-UHFFFAOYSA-N 0.000 claims description 2
- JZKFHQMONDVVNF-UHFFFAOYSA-N dodecyl sulfate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCOS(O)(=O)=O JZKFHQMONDVVNF-UHFFFAOYSA-N 0.000 claims description 2
- 150000002191 fatty alcohols Chemical class 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 229940116338 glyceryl ricinoleate Drugs 0.000 claims description 2
- 229940075529 glyceryl stearate Drugs 0.000 claims description 2
- 229940075468 lauramidopropyl betaine Drugs 0.000 claims description 2
- 229940094506 lauryl betaine Drugs 0.000 claims description 2
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 claims description 2
- 229940048848 lauryl glucoside Drugs 0.000 claims description 2
- OAIQHKWDTQYGOK-UHFFFAOYSA-L magnesium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Mg+2].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O.CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O OAIQHKWDTQYGOK-UHFFFAOYSA-L 0.000 claims description 2
- HBNDBUATLJAUQM-UHFFFAOYSA-L magnesium;dodecyl sulfate Chemical compound [Mg+2].CCCCCCCCCCCCOS([O-])(=O)=O.CCCCCCCCCCCCOS([O-])(=O)=O HBNDBUATLJAUQM-UHFFFAOYSA-L 0.000 claims description 2
- 229940044591 methyl glucose dioleate Drugs 0.000 claims description 2
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 claims description 2
- 230000021332 multicellular organism growth Effects 0.000 claims description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 2
- BOUCRWJEKAGKKG-UHFFFAOYSA-N n-[3-(diethylaminomethyl)-4-hydroxyphenyl]acetamide Chemical compound CCN(CC)CC1=CC(NC(C)=O)=CC=C1O BOUCRWJEKAGKKG-UHFFFAOYSA-N 0.000 claims description 2
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 claims description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 claims description 2
- 229940049964 oleate Drugs 0.000 claims description 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 2
- 229940100460 peg-100 stearate Drugs 0.000 claims description 2
- 229940032067 peg-20 stearate Drugs 0.000 claims description 2
- 229940029223 peg-200 hydrogenated glyceryl palmate Drugs 0.000 claims description 2
- 229940086539 peg-7 glyceryl cocoate Drugs 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 235000021118 plant-derived protein Nutrition 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 229940079988 potassium cocoyl glycinate Drugs 0.000 claims description 2
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 claims description 2
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 claims description 2
- 235000018102 proteins Nutrition 0.000 claims description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims description 2
- 108700004121 sarkosyl Proteins 0.000 claims description 2
- 229940079781 sodium cocoyl glutamate Drugs 0.000 claims description 2
- 229940079776 sodium cocoyl isethionate Drugs 0.000 claims description 2
- 229940057950 sodium laureth sulfate Drugs 0.000 claims description 2
- 229940102544 sodium laureth-13 carboxylate Drugs 0.000 claims description 2
- 229940045944 sodium lauroyl glutamate Drugs 0.000 claims description 2
- 229940007636 sodium lauroyl methyl isethionate Drugs 0.000 claims description 2
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 claims description 2
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 claims description 2
- 229940048109 sodium methyl cocoyl taurate Drugs 0.000 claims description 2
- ODFAPIRLUPAQCQ-UHFFFAOYSA-M sodium stearoyl lactylate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O ODFAPIRLUPAQCQ-UHFFFAOYSA-M 0.000 claims description 2
- 229940080352 sodium stearoyl lactylate Drugs 0.000 claims description 2
- 229940102541 sodium trideceth sulfate Drugs 0.000 claims description 2
- IWIUXJGIDSGWDN-UQKRIMTDSA-M sodium;(2s)-2-(dodecanoylamino)pentanedioate;hydron Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O IWIUXJGIDSGWDN-UQKRIMTDSA-M 0.000 claims description 2
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 claims description 2
- KLYDBHUQNXKACI-UHFFFAOYSA-M sodium;2-[2-(2-tridecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O KLYDBHUQNXKACI-UHFFFAOYSA-M 0.000 claims description 2
- NVIZQHFCDBQNPH-UHFFFAOYSA-M sodium;2-dodecanoyloxypropane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)OC(C)CS([O-])(=O)=O NVIZQHFCDBQNPH-UHFFFAOYSA-M 0.000 claims description 2
- QUCDWLYKDRVKMI-UHFFFAOYSA-M sodium;3,4-dimethylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1C QUCDWLYKDRVKMI-UHFFFAOYSA-M 0.000 claims description 2
- 229950004959 sorbitan oleate Drugs 0.000 claims description 2
- 229950003429 sorbitan palmitate Drugs 0.000 claims description 2
- 229950011392 sorbitan stearate Drugs 0.000 claims description 2
- 235000019337 sorbitan trioleate Nutrition 0.000 claims description 2
- 229960000391 sorbitan trioleate Drugs 0.000 claims description 2
- 239000001589 sorbitan tristearate Substances 0.000 claims description 2
- 235000011078 sorbitan tristearate Nutrition 0.000 claims description 2
- 229960004129 sorbitan tristearate Drugs 0.000 claims description 2
- 239000008117 stearic acid Substances 0.000 claims description 2
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 239000003760 tallow Substances 0.000 claims description 2
- 229940095064 tartrate Drugs 0.000 claims description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical class CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 230000003213 activating effect Effects 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 239000011149 active material Substances 0.000 abstract description 8
- 150000003016 phosphoric acids Chemical class 0.000 abstract 1
- 150000003871 sulfonates Chemical class 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 36
- 239000000499 gel Substances 0.000 description 34
- 239000002994 raw material Substances 0.000 description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 230000008901 benefit Effects 0.000 description 10
- 244000290333 Vanilla fragrans Species 0.000 description 9
- 239000006260 foam Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 210000004209 hair Anatomy 0.000 description 8
- 240000007817 Olea europaea Species 0.000 description 7
- 238000009826 distribution Methods 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 206010040914 Skin reaction Diseases 0.000 description 6
- 235000009499 Vanilla fragrans Nutrition 0.000 description 6
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000035483 skin reaction Effects 0.000 description 6
- 231100000430 skin reaction Toxicity 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 239000002775 capsule Substances 0.000 description 5
- 210000004761 scalp Anatomy 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 3
- 235000004936 Bromus mango Nutrition 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 240000007228 Mangifera indica Species 0.000 description 3
- 235000014826 Mangifera indica Nutrition 0.000 description 3
- 235000009184 Spondias indica Nutrition 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000004973 liquid crystal related substance Substances 0.000 description 3
- 230000002535 lyotropic effect Effects 0.000 description 3
- 210000004400 mucous membrane Anatomy 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 230000036555 skin type Effects 0.000 description 3
- 230000007480 spreading Effects 0.000 description 3
- 238000003892 spreading Methods 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000012612 commercial material Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- UDHXJZHVNHGCEC-UHFFFAOYSA-N Chlorophacinone Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)C(=O)C1C(=O)C2=CC=CC=C2C1=O UDHXJZHVNHGCEC-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940008960 coco-caprylate-caprate Drugs 0.000 description 1
- 239000004567 concrete Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 101150042537 dld1 gene Proteins 0.000 description 1
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 1
- 229940059082 douche Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960004279 formaldehyde Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 239000005431 greenhouse gas Substances 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000012764 mineral filler Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000012766 organic filler Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 1
- 229940081510 piroctone olamine Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 229940079862 sodium lauryl sarcosinate Drugs 0.000 description 1
- ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 description 1
- HSFQBFMEWSTNOW-UHFFFAOYSA-N sodium;carbanide Chemical group [CH3-].[Na+] HSFQBFMEWSTNOW-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0295—Liquid crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/88—Ampholytes; Electroneutral compounds
- C11D1/94—Mixtures with anionic, cationic or non-ionic compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/0008—Detergent materials or soaps characterised by their shape or physical properties aqueous liquid non soap compositions
- C11D17/0026—Structured liquid compositions, e.g. liquid crystalline phases or network containing non-Newtonian phase
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/04—Detergent materials or soaps characterised by their shape or physical properties combined with or containing other objects
- C11D17/041—Compositions releasably affixed on a substrate or incorporated into a dispensing means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/596—Mixtures of surface active compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/02—Anionic compounds
- C11D1/12—Sulfonic acids or sulfuric acid esters; Salts thereof
- C11D1/14—Sulfonic acids or sulfuric acid esters; Salts thereof derived from aliphatic hydrocarbons or mono-alcohols
- C11D1/146—Sulfuric acid esters
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
- C11D1/662—Carbohydrates or derivatives
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/88—Ampholytes; Electroneutral compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/88—Ampholytes; Electroneutral compounds
- C11D1/90—Betaines
Definitions
- the present invention relates to a surfactant composition comprising at least one anionic surfactant and at least one compound selected from amphoteric surfactants and nonionic surfactants, and to a cosmetic or dermatological composition comprising a surfactant composition of the invention.
- the present invention finds applications in particular in the field of cosmetics.
- shower gels are generally packaged in flasks, possibly equipped with a pump, or in flexible tubes. They are generally formulated to have a viscosity, in the form of a gel, in order to allow their distribution either by pouring from a bottle, or by pressure of a flexible tube or by pressure exerted on the pump of a pump bottle.
- the gel is usually diluted with water at the time of application to the skin, which also allows the formation of a foam during the massage or friction of the product with the skin.
- the Guhl brand proposed a range of transparent concentrated shampoos in bottle with service capsule.
- the Applicant has managed to develop a personal care product, including skin and hair, meeting precisely these needs by providing a rheofluidifying composition concentrated in surfactants.
- composition having the viscosity of a shower gel, also has the property of being fluidized during spreading.
- the rheological properties of the composition according to the invention allow not only easy spreading on the skin and / or hair, but also to dispense the composition by a spray generator device, if desired by the user.
- the spray diffusion further improves the distribution of the composition on the body and the dilution rate with water, to allow rapid foaming.
- the low viscosity of the formula allows a complete use of the concentrated product: there remains little product in the plastic bottle at the end of use: the rate of refund is optimal.
- composition according to the invention is concentrated at least about 4 times in surfactants, that is to say in foaming active material, with respect to a conventional shower gel. More widely between 3 and 5, or even more widely between 3 and 6.
- composition of the invention therefore has the advantage of being more environmentally friendly than existing body hygiene products, since it may be in a smaller format.
- composition of the invention makes it possible to dispense with preservative, for a benefit of safety for the consumer, and to reduce the impact on the environment.
- Packaging being reduced compared to a conventional product, the Applicant estimates that the consumption of plastic in this context is reduced by about 50% compared to conventional products of the same range.
- the personal care product resulting from the invention is more convenient to use because it is less heavy and more transportable. It can in this context be more easily used in the context of a trip, or use outside the house type sports activities.
- composition of the invention are related to its physicochemical structure.
- the composition of the invention is a "structured" surfactant medium.
- the surfactants contained in the composition are organized in a lyotropic phase of the liquid-crystal type, also called mesophase.
- the phase is optically anisotropic and appears birefringent when viewed in polarized light with an optical microscope. More precisely, it is a lamellar phase, where the surfactants are organized into plane bilayers, also called lamellae.
- the bilayers form a periodic stack by being separated from each other by intermediate layers of water.
- a surfactant composition comprising:
- the total active ingredient of the surfactants is from 25 to 60% by weight relative to the total weight of the composition
- the anionic surfactant ratio is from 0.3 to 0.9
- the amphoteric surfactant ratio is from 0.0 to 0.7
- the nonionic surfactant ratio is from 0.0 to 0.7, the ratio being the ratio between the percentage by weight of active ingredient of the surfactant in the composition and the percentage by weight of total active ingredient of the surfactants in said composition
- the term "active material” means the surfactant present in the commercial raw material containing the surfactant.
- the active ingredient is thus at the origin of the surfactant properties of the raw material containing the surfactant.
- the raw material generally distributed by a supplier, contains, in addition to the active ingredient having surfactant properties, other components, such as water or solvents, reaction residues and related products.
- the percentage of active ingredient in a raw material is obtained by subtracting the percentage of water or solvent, the reaction residues and the ancillary products contained in the raw material to count only the percentage of the surfactant.
- total active ingredient is understood to mean the sum of the active ingredients present in each raw material containing each surfactant and included in the surfactant composition of the invention.
- the total active ingredient of the surfactants may be from 25 to 60% by weight relative to the total weight of the composition, for example from 25 to 55%, or from 35 to 55%, or from 35 to 55% by weight. at 60%, or 30 to 50%, or 35 to 45%.
- the composition of the invention has a pH of from 4.0 to 8.0, the terminals being included.
- the pH may for example be from 4.5 to 7.5, or from 5.0 to 7.0, or from 5.5 to 6.5, the terminals being included.
- the pH may be a physiological pH of between 5.0 and 6.0, the terminals being included.
- the surfactant composition does not contain sodium chloride other than that which can be provided by the surfactants.
- sodium chloride is not added as such during the preparation of the surfactant composition of the invention.
- the surfactant compositions forming part of the composition may contain them, which implies that a small amount of sodium chloride may possibly be detected, especially in trace amounts, in the surfactant composition of the composition. the invention. It may be for example from about 0.005 to about 7.0% by weight of sodium chloride from the surfactant compositions, based on the total weight of said composition, for example between 0.05 and 6.0%, for example strictly less than 2.0%, or strictly less than 3.0%, or strictly less than 4.0%, or strictly less than 5.0%.
- the absence of addition of sodium chloride advantageously confers a better safety of the composition compared to conventional products, in which sodium chloride is added.
- the surfactant composition of the invention has good flow.
- This good flow generally results in a good rheofluidification, that is to say a drop in viscosity of the low shear values (about 1 s -1 ) which can be for example between 0.5 and 20 Pa.s, to low values of high shear viscosity (about 150 s -1 ) which may be for example between 0.01 and 1 Pa.s.
- the surfactant composition of the invention has good sprayability. This can result in a low value of viscosity at high shear and a low value of the flow threshold (for example with a flow threshold ⁇ ⁇ 7Pa), preferably with values close to 3Pa.
- the rheology of the surfactant composition can be measured by any method known to those skilled in the art, for example by forced-constrained flow measurement, using, for example, a Thermo Fisher RS600 imposed stress rotary rheometer.
- the surfactant composition of the invention is devoid of preservatives.
- the composition does not contain any preservative other than the components expressly mentioned as being capable of forming part of the surfactant composition of the invention, for example as surfactant or perfume and which could intrinsically have conservation properties.
- the surfactant composition has the advantage of presenting, without the addition of a dedicated preservative, a stability over time comparable to that of conventional products, in particular those comprising preservatives.
- the surfactant composition of the invention also has the advantage of avoiding the risks associated with the addition of preservatives, such as disturbances of the hormonal system, skin irritations, or skin allergies.
- the preservatives not used in the context of the surfactant composition of the invention are parabens, triclosan, methylisothiazolinone, formaldehyde / formoldehyde liberators and phenoxyethanol, this list not being limiting. , sodium benzoate, salicylic acid, sorbic acid.
- the water is from 40 to 65% by weight relative to the total weight of the surfactant composition.
- it can be 50 to 60%.
- the surfactant composition of the invention therefore has a better environmental impact compared to a conventional product, because the reduction in the water content of the product makes it possible on the one hand to reduce the quantity of water transported, and on the other hand to reduce the packaging quantities of the product compared to a conventional product comprising about 85% water.
- composition of the invention may further comprise at least one fragrance.
- perfume means a perfume raw material or a mixture of perfume raw materials, also called “perfume concentrate", of natural and / or synthetic origin, whether solubilized or not in a solvent for materials. perfume premieres. In other words, it can be any odorous composition or mixture of fragrant raw materials, having olfactory characteristics compatible with a cosmetic use, generally highly concentrated, generally proposed conditioned by a perfumer.
- the solvent may be any suitable solvent known to those skilled in the art, such as, for example, ethanol, Dipropylene glycol, triethylcitrate, isopropyl myristate, triacetin, this list not being limiting.
- Raw materials of natural origin can be any suitable raw material known to those skilled in the art, for example essential oils, concretes, absolutes or plant extracts.
- the proportions between solvent and odoriferous raw materials can be very variable depending on the olfactory power of the fragrant raw materials and their solubility, as conventionally achieved in the field of perfumes, known to those skilled in the art.
- the percentage by weight of perfume in the composition contributes to the approval of the composition, and thus provides a perfume power comparable to that of a conventional product.
- the perfume can as such be concentrated between 2 and 6 times compared to the concentration of a conventional product.
- the percentage of perfume can range from 0.05 to 10% by weight relative to the total weight of the composition, for example from 0.5 to 10%, or from 0.5 to 5.0%, or from 1.0 to 5.0%, or 1 to 10%, or 2 to 10%, or 3 to 10%, or 5 to 10%.
- the perfume can be any commercial perfume composition, for example perfume Lemon Basil (Givaudan) or Acid Berry Perfume (Robertet).
- the perfume can lead to lowering the viscosity of the surfactant mixture to obtain a more fluid product, and / or lowering the flow threshold of the composition, which improves the sprayability.
- the surfactant composition comprises at least one compound chosen from amphoteric surfactants and nonionic surfactants.
- the ratio of amphoteric surfactant is 0.0
- the ratio of nonionic surfactant can not be equal to 0.0
- the value of 0.0 is therefore excluded in this case.
- the ratio of nonionic surfactant is equal to 0.0
- the ratio of amphoteric surfactant can not be equal to 0.0, the value of 0.0 is therefore excluded in this case.
- the anionic surfactant ratio is from 0.3 to 0.9, for example from 0.4 to 0.8, or from 0.5 to 0.7.
- the ratio of amphoteric surfactant is from 0.0 to 0.7, for example from 0.1 to 0.6, or from 0.2 to 0.5.
- the ratio of nonionic surfactant is from 0.0 to 0.7, for example from 0.1 to 0.6, or from 0.2 to 0.5.
- a surfactant composition according to the invention may consist of:
- the total active ingredient of the surfactants is from 25 to 55% by weight relative to the total weight of the composition
- anionic surfactant ratio is from 0.3 to 0.9
- amphoteric surfactant ratio is from 0.0 to 0.7
- the value of 0.0 being excluded and the ratio of of nonionic surfactant is from 0.0 to 0.7, the value of 0.0 being excluded
- the pH of the composition being between 4 and 8.
- a surfactant composition according to the invention may comprise or consist of:
- anionic surfactant ratio is from 0.3 to 0.9
- amphoteric surfactant ratio is from 0.0 to 0.7
- the value of 0.0 being excluded and the ratio of of nonionic surfactant is from 0.0 to 0.7, the value of 0.0 being excluded
- the pH of the composition being between 4 and 8.
- the ratios and percentages indicated above can be measured by any method known to those skilled in the art. It may be for example, in particular for the determination of anionic surfactants, the standard NF ISO 2271 (Determination of the content of anionic active substances by a manual or mechanical method by direct titration in two phases, January 1990, AFNOR).
- the anionic surfactant may be chosen from the group comprising alkyl sulphates, alkyl ether sulphates, sulphonates, phosphoric acid derivatives, phosphates and alkyl phosphates and their derivatives, isethionates, taurates, sulfoccinates, alkyl sulfoacetates, anionic derivatives of plant-derived proteins, amino acids and amino acid derivatives, polypeptides, carboxylic acids and their salts, fatty acid salts derived from saponification, lactic acid derivatives and alkyl polyglucoside derivatives.
- the alkyl sulphates may be chosen from the group comprising sodium lauryl sulphate, sodium coco sulphate, potassium lauryl sulphate, magnesium lauryl sulphate, ammonium lauryl sulphate, triethanolamine lauryl sulphate, diethanolamine lauryl sulphate, monoethanolamine lauryl sulphate and their mixtures;
- the alkyl ether sulfates may be chosen from the group comprising sodium laureth sulfate, sodium trideceth sulfate, ammonium laureth sulfate, magnesium laureth sulfate and triethanolamine laureth sulfate, diethanolamine laurethsulfate, monoethanolamine laurethsulfate, and mixtures thereof;
- the sulphonates may be chosen from the group comprising C14-16 olefin sulphonate sodium, C14-17 sec-Alkyl sulphonate sodium and sodium xylene sulphonate and mixtures thereof;
- the phosphates and alkyl phosphates may be chosen from the group comprising dicetyl phosphate, C12-15 phosphate, potassium cetyl phosphate and C9-15 alkyl phosphate, and mixtures thereof;
- the isethionates may be chosen from the group comprising sodium cocoyl isethionate and sodium Lauroyl Methyl Isethionate and mixtures thereof;
- the taurates may be chosen from the group comprising sodium methyl cocoyl taurate and sodium stearoyl taurate and mixtures thereof;
- the sulphoccinates may be chosen from the group comprising sodium laureth sulphosuccinate, disodium undecylenamido MEA-sulphosuccinate, disodium lauryl sulphosuccinate and disodium ricinoleamido MEA-sulphosuccinate and their mixtures;
- alkyl sulphoacetates may be sodium lauryl sulphoacetate
- anionic derivatives of proteins of plant origin may be chosen from sodium cocoyl apple amino acids, sodium lauroyl oat amino acids, sodium lauroyl wheat amino acids and potassium lauroyl wheat amino acids and mixtures thereof;
- amino acids and amino acid derivatives may be chosen from sodium lauroyl glutamate, sodium cocoyl glutamate, potassium cocoyl glycinate, sodium cocoyl alaninate and sodium lauroyl sarcosinate, and mixtures thereof;
- carboxylic acids and their salts may be chosen from the group comprising sodium lauryl glucose carboxylate and sodium laureth-13 carboxylate and mixtures thereof;
- the salts of fatty acids resulting from the saponification may be chosen from the salts of lauric acid, myristic acid, palmitic acid and stearic acid and their mixtures;
- the lactic acid derivatives may be chosen from sodium stearoyl lactylate, sodium isostearyl lactylate and sodium cocoyl lactylate, and mixtures thereof;
- alkyl polyglucoside derivatives may be chosen from sodium cocoglucoside tartrate, disodium cocopolyglucose sulphosuccinate and disodium cocopolyglucose citrate, and mixtures thereof.
- the at least one amphoteric surfactant may be chosen from the group comprising N-alkylamidobetaines, betaines, sultaines, alkylpolyaminocarboxylates, alkylamphoacetates, their derivatives, and glycine derivatives.
- N-alkylamidobetaines may be chosen from the group comprising cocamidopropyl betaine and lauramidopropyl betaine and mixtures thereof;
- betaines may be chosen from the group comprising coco betaine and lauryl betaine and mixtures thereof;
- the sultaines can be cocamidopropyl hydroxysultaine
- alkylpolyaminocarboxylates may be chosen from the group comprising sodium Carboxymethyl Tallow Polypropylamine and sodium Carboxymethyl Oleyl Polypropylamine and mixtures thereof;
- the alkylamphoacetates may be chosen from the group comprising disodium cocoamphoacetate, sodium cocoamphoacetate and disodium lauroamphoacetate and mixtures thereof;
- the glycine derivatives may be cocoamphopolycarboxyglycinate.
- At least one nonionic surfactant may be chosen from the group comprising the alkypolyglucosides, the glyceryl and fatty acid esters, the sucrose esters of fatty acids and the oxyalkylenated sucrose esters, oxyalkylenated glycerol esters, polyethylene glycol fatty acid esters, fatty acid and sorbitan esters, polyglycerolated fatty alcohols and glucamine derivatives.
- alkypolyglucosides may be chosen from the group comprising decyl glucoside, lauryl glucoside, caprylyl / capryl glucoside and coco glucoside, and mixtures thereof;
- the glyceryl and fatty acid esters may be chosen from glyceryl stearate, glyceryl ricinoleate and glyceryl oleate, and mixtures thereof;
- the sucrose esters of fatty acids may be chosen from sucrose stearate, sucrose palmitate, sucrose laurate and sucrose distearate, and mixtures thereof;
- the oxyalkylenated sucrose esters may be chosen from methyl glucose caprate / caprylate / oleate, PEG-120 methyl glucose dioleate and PEG-20 methyl glucose sesquistearate, and mixtures thereof;
- the oxyalkylenated glycerol esters may be chosen from PEG-7 glyceryl cocoate, PEG-80 glyceryl cocoate, PEG-30 glyceryl cocoate and PEG-200 hydrogenated glyceryl palmate, and mixtures thereof;
- the fatty acid and polyethylene glycol esters may be chosen from the group PEG-8 stearate, PEG-20 stearate, PEG-40 stearate, PEG-50 stearate and PEG-100 stearate, and mixtures thereof ;
- the fatty acid and sorbitan esters may be chosen from the group comprising sorbitan palmitate, sorbitan stearate, sorbitan tristearate, sorbitan oleate and sorbitan trioleate, and mixtures thereof;
- the glucamine derivatives may be chosen from the group comprising capryloyl or caproyl methyl glucamide, lauroyl methyl glucamide, lauroyl methyl glucamide and cocoyl methyl glucamide, and mixtures thereof.
- the anionic surfactant may be an alkyl sulfate
- the amphoteric surfactant may be an N-alkylamidobetaine or an alkylamphoacetate
- the nonionic surfactant may be an alkypolyglucoside
- the anionic surfactant may be ammonium lauryl sulfate
- the amphoteric surfactant may be cocamidopropyl betaine or sodium cocoamphoacetate
- the nonionic surfactant may be decylglucoside.
- the surfactant composition according to the invention may constitute in particular a composition for cutaneous application, used in particular in the cosmetic or dermatological fields, as cleansing products for the skin, including the body and the face, the scalp and / or hair.
- a composition for topical application may optionally contain a physiologically acceptable medium, that is to say compatible with the skin, mucous membranes, scalp and / or hair. It may more particularly constitute a composition for cleaning the skin.
- the surfactant composition may be in a form chosen from a shower gel, a cleansing gel for the skin of the face, a shampoo and a washing gel for the hands.
- the surfactant composition of the invention may be present in a package chosen from a bottle, for example of the type a bottle provided with a capsule or a pump (metering or spray), a tube, by example a flexible tube and a pot.
- the surfactant composition of the invention does not comprise a preservative, this being favorable to a better safety, as indicated above.
- Another subject of the invention relates to a cosmetic or dermatological composition
- a cosmetic or dermatological composition comprising a surfactant composition according to the invention.
- the cosmetic or dermatological composition may be constituted, that is to say exclusively include the surfactant composition of the invention.
- the cosmetic composition may comprise a cosmetically acceptable vehicle.
- the cosmetic composition of the invention has the same rheo-fluidifying properties as the other advantageous properties that the surfactant composition of the invention.
- cosmetic composition in the present invention, any cosmetic composition, ie aesthetic, which can be brought into contact with the superficial parts of the human body, for example the epidermis, the hair and capillary systems, the external organs and the external mucous membranes.
- a cosmetic composition allows, exclusively or mainly to clean, protect or maintain in good condition.
- the term "dermatological composition” is intended to mean any composition for dermatological purposes, ie a composition that can be brought into contact with the superficial parts of the human body, for a treatment of the skin, mucous membranes and integuments, nails , hair, hairs.
- cosmetically or dermatologically acceptable vehicle is meant a vehicle adapted for use in contact with cutaneous human and animal cells, in particular the cells of the epidermis, without toxicity, irritation, undue allergic response and the like, and proportionate to a reasonable benefit / risk ratio.
- the vehicle is used in proportions compatible with the high concentration of the composition of the invention.
- the cosmetic composition of the invention may furthermore comprise adjuvants conventionally used in the cosmetic field, chosen from oils, vegetable butters, vegetable or synthetic waxes, actives, perfumes, preservatives, sequestering agents (EDTA), antioxidants, cationic polymers and cationic surfactants, pearlescent and opacifying agents, pigments, mineral or organic fillers such as talc, kaolin, starch, exfoliants (solid particles vegetable, mineral or synthetic having an abrasive effect on the skin), nacres and flakes, dyes, sunscreens, acids and bases for pH adjustment, synthetic or natural gelling polymers.
- adjuvants conventionally used in the cosmetic field, chosen from oils, vegetable butters, vegetable or synthetic waxes, actives, perfumes, preservatives, sequestering agents (EDTA), antioxidants, cationic polymers and cationic surfactants, pearlescent and opacifying agents, pigments, mineral or organic fillers such as talc, kaolin, starch, exfoliants (
- oils include vegetable oils, such as jojoba, avocado, sesame, sunflower, rapeseed, corn, soybean, safflower, and grape seed, or mineral oils, such as paraffin oils, or synthetic oils, such as isopropyl myristate, cococaprylate caprate, ethylhexyl palmitate and alkyl benzoate, or volatile or non-volatile silicone oils such as polydimethylsiloxanes (PDMS), cyclodimethylsiloxanes or cyclomethicones, or fluorinated or fluorosilicone oils, or naturally occurring alkanes, as well as mixtures of these oils.
- the amount of oil should not change the desired property for the composition of the invention.
- active agents examples include moisturizers and, for example, polyols such as glycerine, glycols, polyethylene glycols and sugars and their derivatives, natural extracts, piroctone olamine, zinc pyrithione, salicylic acid, urea, vitamins and their derivatives (D panthenol or tocopherol acetate for example), protein hydrolysates and amino acids.
- composition of the invention can be obtained by any suitable method known to those skilled in the art for the manufacture of a foaming cosmetic composition. It may be, for example a simple mixture.
- the composition may be a composition for cutaneous use.
- the cosmetic composition may be in a form chosen from a shower gel, a facial skin cleansing gel, a shampoo, a hand washing gel and a household cleaning product, for example a dishwashing liquid, a multi-purpose household cleaning gel, a household cleaning product.
- Another subject of the invention relates to a cosmetic use of the cosmetic composition according to the invention for cleaning the skin and / or the integuments and / or the scalp.
- Another subject of the invention relates to a non-therapeutic cosmetic treatment method comprising the application to the skin and / or the superficial body growths and / or the scalp of a surfactant composition of the invention or a composition cosmetic according to the invention.
- the cosmetic treatment process may be a method for cleaning the dirt residues of human keratinous materials (also cleaning sweat and lipids), in which the cosmetic composition of the invention is applied to the skin and / or dander and / or the scalp in the presence of water.
- the application may include a massage to form a foam, which may be removed with the soil residues by rinsing with water.
- the use means a non-therapeutic use, for example for the treatment of healthy skin, that is to say say skin that does not have a pathological condition. It may also be skin that does not have a visible or noticeable trace of external aggression, such as itching, sunburn, burns, bites, signs of inflammation, sores. being not limiting.
- any cosmetic use and any cosmetic process according to the invention are respectively non-therapeutic cosmetic uses and non-therapeutic cosmetic processes.
- Another subject of the invention relates to a combination between a spray-generating device or a device for delivering a dose and a surfactant composition or a cosmetic composition according to the invention, in which the spray-generating device diffuses into a spray. the cosmetic composition or the surfactant composition.
- the device for delivering a dose may for example be a valve capsule, for example a Capsule-type capsule capsule.
- Invio - ref V143-145 marketed by the Seaquist Supplier of the Aptar Group.
- the surfactant composition of the invention having a viscosity comparable to conventional shower gels but being shear thinning, is sprayable, that is to say it can be dispensed by means of a spray generator device.
- the distribution by means of a spray-generating device of the cosmetic composition or of the surfactant composition according to the invention facilitates the distribution of the composition on the keratin materials, in particular facilitates the distribution of a small amount of composition ( as the formula is very concentrated) over a large area.
- the surfactant composition of the invention being rheo-fluidifying, it allows, in combination with a spray distribution, the easy distribution of a lower product dose, for example 4 times lower, than with a gel conventional shower, for a surface of keratinous material, especially skin, identical to or greater than that covered by a larger amount of conventional product.
- the spray generator device can be any device available on the market, for example a dosing pump bottle provided with a spray pump, for example the PZ2 190 DLD1 Helios pump (Aptar).
- FIG. 1 represents an X-ray photograph of a concentrated shower gel composition.
- X-rays are produced by a 40 kV 40 mA copper rotating anode, 40 cm in diameter. The exposure time is 2 hours (8 times of 15 minutes each).
- the sample is in the form of a capillary 1.5 mm in diameter, placed in a sample holder thermostated at 20 ° C.
- the diffraction pattern is characteristic of a lamellar phase; it consists of two fine rings (order 1 and order 2 of diffraction).
- the observation mode of FIG. 1 makes it possible to characterize the non-wound planar lamellar phase structure.
- FIG. 2 represents an optical microscope photograph of the shower gel composition object of FIG. 1, in Differential Interference Contrast.
- Cocamidopropyl betaine (amphoteric surfactant) and decylglucoside (nonionic surfactant) are added in water at room temperature (about 20 ° C.).
- the citric acid is then added to the mixture at room temperature.
- the perfume is then added to the mixture, followed by ammonium lauryl sulphate (anionic surfactant); everything is mixed at room temperature.
- Example 2 Example of a surfactant composition
- Table I above illustrates a surfactant composition of the invention, with the concentrations of its components, of active material.
- This formula is concentrated about 4X compared to a conventional shower gel.
- This formula has the property of being fluidized with the spreading.
- the surfactants contained in the composition are organized in a lyotropic phase of the liquid crystal type; the phase is optically anisotropic and appears birefringent when observed in polarized light with an optical microscope. More precisely, it is a lamellar phase, where the surfactants are organized into plane bilayers, also called lamellae.
- the bilayers form a periodic stack by being separated from each other by intermediate layers of water.
- Example 3 Example of a surfactant composition
- Table II illustrates a surfactant composition of the invention, with the concentrations of its components, in active material and commercial material.
- the surfactants contained in the composition are organized in a lyotropic phase of the liquid crystal type; the phase is optically anisotropic and appears birefringent when observed in polarized light with an optical microscope. More precisely, it is a lamellar phase, where the surfactants are organized into plane bilayers, also called lamellae.
- the bilayers form a periodic stack by being separated from each other by intermediate layers of water.
- Table III below illustrates 8 surfactant compositions of the invention, with the concentrations of its components, in active material and commercial material.
- the composition was applied once a day for 7 days under normal conditions of use.
- the overall evaluation was done at first use, and after 7 days of use, by a rating of 0 to 10. It reflects satisfaction with use.
- Key indicators are evaluated after 7 days of use. They relate to purchasing indicators, recommendations, preferences and intent to purchase and recommendation after presentation of the concept.
- the foam and the consistency are very well received after 7 days of use, both in terms of quantity, smoothness and fluidity.
- the perfume is positively evaluated (average score of 7.8) after 7 days of use, with customers who judge the scent very "pleasant, pleasure to feel” and "well adapted to a shower gel", with a balanced intensity for the majority.
- the product is out 68
- the scent is pleasant 28 35
- the bottle is convenient 1 74
- the product is out 2 62
- the studied product was applied to the body at least once a day, for 3 consecutive weeks, by 27 healthy adult volunteers.
- the studied product was used instead of the product of the same type that the volunteer usually or occasionally uses.
- the volunteers apply the product studied at home and under normal conditions of use of the product, in place of the one usually used, and according to the indications mentioned in the questionnaire (frequency and duration of use, zone and mode of application ).
- the studied product was applied to the body at least once a day, for 3 consecutive weeks, by 26 healthy adult volunteers.
- the studied product was used instead of the product of the same type that the volunteer usually or occasionally uses.
- the volunteers apply the product studied at home and under normal conditions of use of the product, in place of the one usually used, and according to the indications mentioned in the questionnaire (frequency and duration of use, zone and mode of application ).
- the studied product was applied to the body at least once a day, for 3 consecutive weeks, by 27 healthy adult volunteers.
- the studied product was used instead of the product of the same type that the volunteer usually or occasionally uses.
- the volunteers apply the product studied at home and under normal conditions of use of the product, in place of the one usually used, and according to the indications mentioned in the questionnaire (frequency and duration of use, zone and mode of application ).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Dermatology (AREA)
- Wood Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE17745414.7T DE17745414T1 (de) | 2016-07-01 | 2017-06-30 | Rheo-verflüssigende konzentrierte schäumungszusammensetzung und verwendungen davon, insbesondere für körperhygiene |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1656329A FR3053246B1 (fr) | 2016-07-01 | 2016-07-01 | Composition moussante concentree rheo-fluidifiante et ses utilisations, notamment pour l'hygiene corporelle |
PCT/FR2017/051776 WO2018002557A1 (fr) | 2016-07-01 | 2017-06-30 | Composition moussante concentree rheo-fluidifiante et ses utilisations, notamment pour l'hygiene corporelle |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3478248A1 true EP3478248A1 (fr) | 2019-05-08 |
Family
ID=56943746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17745414.7A Pending EP3478248A1 (fr) | 2016-07-01 | 2017-06-30 | Composition moussante concentree rheo-fluidifiante et ses utilisations, notamment pour l'hygiene corporelle |
Country Status (5)
Country | Link |
---|---|
US (1) | US11701319B2 (fr) |
EP (1) | EP3478248A1 (fr) |
DE (1) | DE17745414T1 (fr) |
FR (2) | FR3053246B1 (fr) |
WO (1) | WO2018002557A1 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11376207B2 (en) | 2017-10-31 | 2022-07-05 | L'oreal | Hair care compositions |
US11123276B2 (en) * | 2018-02-28 | 2021-09-21 | L'oreal | Cosmetic compositions |
MX2020011785A (es) | 2018-05-11 | 2020-11-24 | Unilever Ip Holdings B V | Composicion limpiadora sin sulfatos. |
WO2019215254A1 (fr) | 2018-05-11 | 2019-11-14 | Unilever Plc | Composition de lavage |
FR3081708B1 (fr) * | 2018-05-31 | 2020-12-25 | Oreal | Composition cosmetique nettoyante comprenant deux tensioactifs |
US11096878B2 (en) | 2018-05-31 | 2021-08-24 | L'oreal | Concentrated rinse-off cleansing composition |
US11633339B2 (en) | 2018-09-07 | 2023-04-25 | L'oreal | Cleansing compositions free of sodium chloride and sulfate-based surfactants |
FR3098718B1 (fr) * | 2019-07-18 | 2021-12-10 | Laboratoires De Biologie Vegetale Yves Rocher | Composition moussante concentrée rhéo-fluidifiante sans sulfate et ses utilisations, notamment pour l’hygiène corporelle |
CN111437219B (zh) * | 2019-10-31 | 2022-12-20 | 上海新如生物科技有限公司 | 一种弱酸性沐浴乳及其制备方法 |
EP4057985A1 (fr) | 2019-11-11 | 2022-09-21 | Unilever IP Holdings B.V. | Composition de nettoyage |
CA3160782C (fr) | 2020-02-28 | 2024-03-26 | Fabrizio Meli | Procede d'elimination de contaminants chimiques |
CA3181918A1 (fr) * | 2020-05-05 | 2021-11-11 | The Procter & Gamble Company | Compositions comprenant des tensioactifs et des co-tensioactifs non ethoxyles permettant d'obtenir une bonne consistance et de bonnes performances du produit |
CN111616972A (zh) * | 2020-05-13 | 2020-09-04 | 名臣健康用品股份有限公司 | 一种低成本自增稠温和无硫酸盐洗发组合物及其制备方法 |
MX2023012992A (es) | 2021-05-04 | 2023-11-15 | Unilever Ip Holdings B V | Composicion tensoactiva concentrada hidratable sustancialmente libre de isetionatos. |
EP4362884A1 (fr) | 2021-07-02 | 2024-05-08 | Unilever IP Holdings B.V. | Ester comprenant une composition de tensioactif concentrée hydratable |
EP4362883A1 (fr) | 2021-07-02 | 2024-05-08 | Unilever IP Holdings B.V. | Composition de tensioactif concentrée hydratable comprenant un composé ayant un pourcentage en poids d'oxygène défini |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5846160B2 (ja) * | 1978-07-13 | 1983-10-14 | 花王株式会社 | シヤンプ−組成物 |
GB9301270D0 (en) * | 1993-01-22 | 1993-03-17 | Unilever Plc | Dilution-thickening,personal washing composition |
US5925615A (en) * | 1998-03-06 | 1999-07-20 | Nu Skin International, Inc. | Awapuhi (Zingiber zerumbet) -containing hair cleansing and conditioning compositions |
AU2001276913B2 (en) * | 2000-07-14 | 2005-09-01 | Johnson And Johnson Consumer Companies, Inc. | Self foaming cleansing gel |
CA2524589A1 (fr) * | 2003-05-07 | 2004-11-18 | Ifac Gmbh & Co. Kg | Compositions permettant une liberation ciblee de parfums et d'aromes |
EP2069470B1 (fr) * | 2006-09-26 | 2021-03-24 | Solvay USA Inc. | Système tensioactif structuré |
US8778910B2 (en) * | 2012-12-07 | 2014-07-15 | Conopco, Inc. | Concentrated lamellar liquid personal cleansing composition |
FR3025101B1 (fr) * | 2014-08-28 | 2017-12-29 | Oreal | Composition moussante comprenant au moins un tensio-actif du type n-acylsarcosinate |
-
2016
- 2016-07-01 FR FR1656329A patent/FR3053246B1/fr active Active
-
2017
- 2017-06-30 DE DE17745414.7T patent/DE17745414T1/de active Pending
- 2017-06-30 WO PCT/FR2017/051776 patent/WO2018002557A1/fr unknown
- 2017-06-30 EP EP17745414.7A patent/EP3478248A1/fr active Pending
- 2017-06-30 US US16/314,604 patent/US11701319B2/en active Active
-
2019
- 2019-07-09 FR FR1907680A patent/FR3083447B1/fr active Active
Also Published As
Publication number | Publication date |
---|---|
US11701319B2 (en) | 2023-07-18 |
US20190314258A1 (en) | 2019-10-17 |
FR3083447B1 (fr) | 2022-04-15 |
FR3053246B1 (fr) | 2019-10-18 |
FR3053246A1 (fr) | 2018-01-05 |
DE17745414T1 (de) | 2019-12-19 |
FR3083447A1 (fr) | 2020-01-10 |
WO2018002557A1 (fr) | 2018-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2018002557A1 (fr) | Composition moussante concentree rheo-fluidifiante et ses utilisations, notamment pour l'hygiene corporelle | |
EP3664769B1 (fr) | Emulsion moussante a haute teneur en huile et ses utilisations, notamment pour l'hygiene corporelle | |
Toedt | Chemical composition of everyday products | |
EP3622946B1 (fr) | Composition cosmetique capillaire a base d'aloe vera et d'huile de noix de coco et son procede de preparation | |
WO2021009445A1 (fr) | Composition moussante concentree rheo-fluidifiante sans sulfate et ses utilisations | |
EP1759688A1 (fr) | Procédé cosmétique de soin des peaux grasses et kit associé | |
EP1174122A1 (fr) | Composition cosmétique de nettoyage | |
EP0830126B1 (fr) | Pseudo-emulsions stabilisees et leur procede de preparation | |
CH709223B1 (fr) | Particules de cellulose exfoliantes et utilisations cosmétiques de celles-ci. | |
CA3160196A1 (fr) | Compositions cosmetiques nettoyantes sous forme de poudre | |
JP6062538B2 (ja) | 輝きをもたらす組成物及び使用方法 | |
CN101940541A (zh) | 无脂肪酸的发泡化妆品组合物和使用方法 | |
FR2878440A1 (fr) | Composition de nettoyage sous forme de mousse aerosol sans tensioactif anionique et utilisations en cosmetique | |
FR2939658A1 (fr) | Composition moussante comprenant une gomme de guar modifiee | |
FR2890858A1 (fr) | Composition demaquillante | |
FR3081708A1 (fr) | Composition cosmetique nettoyante comprenant deux tensioactifs | |
FR2968952A1 (fr) | Ester d'acide amine n-acyle a titre d'agent apaisant | |
Bartkutė | Formulation and Evaluation of Herbal Shampoo | |
Huanbutta et al. | Dissolvable shower gel tablets with enhanced skin benefits | |
WO2024133224A1 (fr) | Composition cosmétique sous forme de suspension stable | |
WO2022084612A1 (fr) | Composition cosmétique transparente, sans sulfates a haute teneur en parfum | |
FR3018192A1 (fr) | Composition cosmetique comprenant de la gomme de sclerotium (sclerotium gum) | |
FR2949969A1 (fr) | Composition cosmetique a base d'uree pure, utilisation et procede d'application correspondant | |
FR2968988A1 (fr) | Huile essentielle de fabiana imbricata a titre d'agent apaisant. | |
FR2968986A1 (fr) | Utilisation d'un extrait d'eryngium alpinium dans une composition cosmetique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20190129 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20210421 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230420 |